|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07F 5/02 | (2006.01) |
| A61K 31/69 | (2006.01) | ||
| A61K 33/22 | (2006.01) | ||
| A61P 29/00 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3840837 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19758683.7 |
| Date of filing the European patent application | 2019-08-21 | |
| (97) | Date of publication of the European application | 2021-06-30 |
| (45) | Date of publication and mention of the grant of the patent | 2024-03-20 |
| (46) | Date of publication of the claims translation | 2024-06-10 |
| (86) | Number | PCT/EP2019/072341 |
| Date | 2019-08-21 |
| (87) | Number | WO 2020/038983 |
| Date | 2020-02-27 |
| (30) | Number | Date | Country code |
| 201862721113 P | 2018-08-22 | US |
| (72) |
WU, Dedong , US
|
| (73) |
Astrazeneca AB ,
151 85 Södertälje,
SE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Arginazės inhibitoriai ir jų panaudojimo būdai |
| ARGINASE INHIBITORS AND METHODS OF USE THEREOF |
| Payment date | Validity (years) | Amount | |
| 2025-07-23 | 7 | 162.00 EUR |
| 2026-08-21 |